Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 78 peer-reviewed journal articles Updated
Infectious Disease

Eumycotic Mycetoma: A Patient Guide

At a Glance

Eumycotic mycetoma is a slow-growing fungal infection that can cause swelling, draining tunnels, and grains after a skin injury. Diagnosis distinguishes it from bacterial mycetoma, and treatment often combines long-term antifungal medicine, surgery, and years of follow-up.

Eumycotic mycetoma is a chronic, localized infection caused by several types of fungi found in soil and on thorny plants. It typically begins when the fungus is introduced into the body through a minor injury, such as a thorn prick or a splinter, often while working outdoors or walking barefoot in agricultural settings [1]. Because the infection is usually painless in its early stages and grows very slowly, it is common for patients to wait months or even years before seeking medical attention [2][3].

What should I do next? This infection is not spread person-to-person. Confirming the diagnosis requires specialist medical assessment. Do not self-start antifungals or delay assessment while waiting for advanced testing.

As the infection progresses, it develops a classic “triad” of symptoms that help doctors identify it: a firm, localized swelling under the skin, the formation of small “tunnels” or sinus tracts that lead to the surface, and the discharge of tiny, seed-like particles called grains [4]. These grains are compact aggregates of fungal elements and host tissue [5]. While the infection often stays in the soft tissue, if left untreated, it carries a risk of gradually involving the underlying muscle and eventually the bone [6][7].

A precise diagnosis helps guide treatment because eumycetoma can look identical to a similar bacterial infection called actinomycetoma. Because the treatments for fungi and bacteria are completely different, your medical team uses specialized tests—including clinical examination, imaging, microscopy, biopsies, cultures, and selectively molecular PCR testing—to identify the exact species of fungus involved [8][9]. Knowing the specific fungus helps choose the right medication and plan the surgical approach, although treatment often begins on the best available evidence [10].

Managing eumycetoma usually requires an individualized approach that combines long-term antifungal therapy with surgical intervention [11]. Medication is used to treat the fungal mass, while surgery is used to physically remove infected tissue based on depth and anatomic extent [12]. This is a long journey that often requires taking medication for a year or more [11][13].

Even after a successful treatment and surgery, the fungus is known for its ability to hide and return, leading to a risk of recurrence. This makes long-term surveillance and regular follow-up appointments with your care team essential for many years after the initial infection has cleared [14][15]. While the road to recovery is long, a combination of specialized medical care and consistent monitoring offers the best path toward reclaiming your health and mobility [4][16].

In this guide

6 chapters

01

Understanding Your Mycetoma Diagnosis

Learn what an eumycetoma diagnosis means, including symptoms, fungal causes, testing, exposure risks, delayed diagnosis, and when to seek specialist care.

02

Symptoms and How Eumycetoma Behaves

Learn eumycetoma symptoms such as painless lumps, draining sinuses, and grains, plus how infection spreads and when warning signs require urgent care.

03

Diagnostic Tests and Pathology

Learn how eumycetoma is diagnosed with ultrasound, MRI, biopsy, fungal culture, PAS and GMS stains, and PCR testing to identify the fungus and guide treatment.

04

Standard of Care and Treatment Strategy

Learn how eumycetoma treatment combines long-term itraconazole, surgery, liver monitoring, and follow-up to define cure and reduce recurrence risk over time.

05

Daily Management and Medication Safety

Learn how to manage eumycotic mycetoma safely, take itraconazole correctly, monitor side effects, care for draining wounds, and prevent reinfection at home.

06

Life After Treatment and Long-Term Care

Learn how to monitor eumycetoma after treatment, recognize recurrence, plan follow-up, rebuild mobility, and manage emotional health during long-term care.

Common questions in this guide

How is eumycotic mycetoma different from bacterial mycetoma?
Eumycotic mycetoma is caused by fungi, while actinomycetoma is caused by bacteria. The two infections can look alike, so examination, imaging, microscopy, biopsy, culture, or molecular testing may be needed to guide the right treatment.
What do the swelling, tunnels, and grains mean?
The typical pattern is a firm swelling under the skin, small draining tunnels called sinus tracts, and tiny seed-like grains in the discharge. The grains are compact collections of fungal material and body tissue.
What tests are used to diagnose eumycotic mycetoma?
Doctors may use a physical examination, imaging, microscopy, a biopsy, and fungal cultures to confirm the infection and identify the fungus. Molecular PCR testing may be used selectively when more information is needed.
Does eumycotic mycetoma usually need both medicine and surgery?
Treatment is individualized, but it often combines long-term antifungal medicine with surgery to remove infected tissue. Medication may be needed for a year or longer, depending on how extensive and deep the infection is.
Can eumycotic mycetoma spread or come back after treatment?
Without treatment, the infection can gradually extend from soft tissue into muscle and bone. It can also recur after treatment, so regular follow-up and long-term surveillance are often important.
Is eumycotic mycetoma contagious?
No, eumycotic mycetoma is not spread from person to person. It usually begins when fungi from soil or thorny plants enter the body through a minor injury.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on eumycotic mycetoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my case confirmed as fungal (eumycetoma) rather than bacterial (actinomycetoma)?
  2. 2.Which specific fungal species is causing my infection?
  3. 3.Based on my imaging, how far has the infection spread into my muscle or bone?
  4. 4.What is the long-term plan for combining medication with surgery in my case?
  5. 5.How will we monitor for the infection returning once my treatment is finished?

References

References (16)
  1. 1

    Modelling the spatial distribution of mycetoma in Sudan.

    Hassan R, Simpson H, Cano J, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(10)):1144-1152 doi:10.1093/trstmh/trab076.

    PMID: 34037803
  2. 2

    Long term follow-up of Maduromycosis treatment: A case review.

    Saleh R, Nong I, Guatama A, et al.

    International journal of surgery case reports 2021; (82()):105956 doi:10.1016/j.ijscr.2021.105956.

    PMID: 33984729
  3. 3

    Dot-in-Circle Sign - A Diagnostic MRI Sign for "Madura Foot".

    Javed F, Nazir R, Sharma M, et al.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2017; (27(3)):S8-S10 doi:236.

    PMID: 28302229
  4. 4

    Mycetoma: reviewing a neglected disease.

    Verma P, Jha A

    Clinical and experimental dermatology 2019; (44(2)):123-129 doi:10.1111/ced.13642.

    PMID: 29808607
  5. 5

    Surgical Management and Antifungal Therapy for Extensive Eumycetoma of the Right Foot: A Case Report from Resource Limited Settings.

    Ali TA, Mahamud MA, Hassan SA, et al.

    International medical case reports journal 2026; (19()):593386 doi:10.2147/IMCRJ.S593386.

    PMID: 41836465
  6. 6

    Advanced Eumycetoma of the Right Foot Resulting in Below-Knee Amputation in Somalia: A Case Report.

    Mahamud MA, Ahmed MM, Hassan SA, et al.

    International medical case reports journal 2026; (19()):633948 doi:10.2147/IMCRJ.S633948.

    PMID: 42808000
  7. 7

    Madura's foot: reasons for the delay in diagnosis and consequences for the management (a case report).

    Boanimbek B, Aznague Y, Abass GO, et al.

    The Pan African medical journal 2020; (37()):75 doi:10.11604/pamj.2020.37.75.24983.

    PMID: 33244338
  8. 8

    Mycetoma imaging: the best practice.

    Bahar ME, Bakheet OELH, Fahal AH

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):387-396 doi:10.1093/trstmh/traa178.

    PMID: 33537774
  9. 9

    Comparing the performance of the common used eumycetoma diagnostic tests.

    Siddig EE, Nyuykonge B, Mhmoud NA, et al.

    Mycoses 2023; (66(5)):420-429 doi:10.1111/myc.13561.

    PMID: 36583225
  10. 10

    Madurella real-time PCR, a novel approach for eumycetoma diagnosis.

    Arastehfar A, Lim W, Daneshnia F, et al.

    PLoS neglected tropical diseases 2020; (14(1)):e0007845 doi:10.1371/journal.pntd.0007845.

    PMID: 31940343
  11. 11

    Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial.

    Fahal AH, Ahmed ES, Bakhiet SM, et al.

    The Lancet. Infectious diseases 2024; (24(11)):1254-1265 doi:10.1016/S1473-3099(24)00404-3.

    PMID: 39098321
  12. 12

    [Eumycetoma due to Fusarium chlamydosporum : Case report und review of the literature].

    Malisiewicz B, Uhrlaß S, Nenoff P, Schöfer H

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(8)):612-617 doi:10.1007/s00105-019-4430-8.

    PMID: 31289888
  13. 13

    Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.

    Nenoff P, van de Sande WW, Fahal AH, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(10)):1873-83 doi:10.1111/jdv.13008.

    PMID: 25726758
  14. 14

    Predictors of Post-operative Mycetoma Recurrence Using Machine-Learning Algorithms: The Mycetoma Research Center Experience.

    Wadal A, Elhassan TA, Zein HA, et al.

    PLoS neglected tropical diseases 2016; (10(10)):e0005007 doi:10.1371/journal.pntd.0005007.

    PMID: 27798643
  15. 15

    Clinical presentation, etiology, and treatment outcomes of mycetoma: A 25-year retrospective study in Southern Thailand.

    Chittrakarn S, Kanchanasuwan S, Sangkakul N, Tongsengkee N

    PLoS neglected tropical diseases 2026; (20(1)):e0013818 doi:10.1371/journal.pntd.0013818.

    PMID: 41564116
  16. 16

    Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens.

    Clark JE, Kim HY, van de Sande WWJ, et al.

    Medical mycology 2024; (62(6)) doi:10.1093/mmy/myae044.

    PMID: 38935904

This page explains eumycotic mycetoma for educational purposes and is not medical advice. A qualified clinician should confirm the diagnosis and tailor antifungal treatment, surgery, and follow-up to your situation.